BridgeBio has significantly advanced the progress of an new treatment for ATTR-CM, utilizing the compound. Early trial results reveals potential benefits for patients affected from this debilitating illness. The https://bridgebio548589.ambien-blog.com/49026744/bridgebio-improves-attr-cm-treatment-using-the-drug